市場調查報告書

西方印漬術市場 - 成長,趨勢,預測

Western Blotting Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921270
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
西方印漬術市場 - 成長,趨勢,預測 Western Blotting Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 110 Pages
簡介

西方印漬術,由於其特異性、低成本、可用性,在市場引人注目。由於在全球的HIV的負擔增加,在生物科技及製藥部門的調查活動的擴大,製藥公司及生物科技公司的研究開發投資的增加等要素帶動市場。

本報告提供西方印漬術的世界市場調查,市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 設備
    • 消耗品
  • 各應用領域
    • 生物醫學、生物化學調查
    • 病診斷
    • 其他
  • 各終端用戶
    • 學界、調查研究機關
    • 診斷中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • LI-COR Biosciences
    • Bio-Techne Corporation
    • GE Healthcare
    • Merck KGaA
    • PerkinElmer, Inc.
    • Cell Signaling Technology
    • Advansta, Inc.
    • Danaher Corporation (Lumigen, Inc.)

第7章 市場機會及未來趨勢

目錄
Product Code: 67106

The western blotting market is majorly driven by factors such as the rising burden of chronic diseases across the globe, growing research activities in the biotech and pharma sector, and raised R&D investment done by pharmaceutical and biotechnology companies.

Western blotting is a widely known and used test that is used in cell and molecular biology. With the help of this test, one can detect the specific type of protein from the complex mixture of proteins that is extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use.

Despite the technique that has been evolved since its inception, there have been several advancements in this technique that occurred in the last decade. Introduction of capillary and microfluidic platforms is one of the advancements which has helped immensely in reducing the time taken for test and decreased the sample requirements along with enabling high-throughput capabilities. Hence, owing to the certain characteristics of the western blot test, the market is believed to witness considerable growth over the forecast period.

Key Market Trends

Disease Diagnostic Segment will be Witnessing a Healthy CAGR Over the Forecast Period

Western blot test is having a wide range of applications in medical diagnostics. For the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), FIV (Feline Immunodeficiency Virus), HBV (Hepatitis B Virus) infection, Lyme Disease among others.

Generally, this test is used as a confirmatory test for the above-mentioned diseases after the ELISA test is done with a positive result. For Lyme Disease, US FDA has suggested the two-tier protocol using an ELISA test initially and then the specific western blot tets for the confirmation of diagnosis if the results of ELISA are positive.

Previously, western blotting was commonly done to confirm the HIV diagnosis. However, the Centre for Disease Control and Prevention (CDC) in the year has recommended discontinuing the Western blot test for HIV as there are novel techniques that came up in the market for HIV detection. Furthermore, studies have suggested that western blot is a priority test for the diagnosis of diseases such as BSE (Bovine Spongiform Encephalopathy), and FIV (Feline Immunodeficiency Virus). Hence, owing to the significance of this test in the disease diagnosis, it is indicated that this segment will be witnessing a healthy CAGR over the forecast period.

North America is Expected to Dominates the Western Blotting Market

The global market for western blotting is dominated by the North America region and the United States holds the largest share of this market. The prime factor contributing to the large share in the United States is the developed healthcare system and the presence of key players in the country.

Companies such as Bio-Rad, Thermo Fisher Scientific, etc are having an active presence in the US market and due to the adaptable nature of US population towards the novel products or technologies, companies are able to establish their novel product launches in the United States which is helping the market studied to grow in this region.

Competitive Landscape

The major players are having competition among themselves for the market share and with the rising application of this test and growing pharmaceutical and biotechnology industries, it is believed that few small to mid-sized companies will penetrate the market soon and hold a substantial share in the market. The major market players operating in the western blotting market include Danaher Corporation, Thermofisher Scientific, Biorad laboratories, Perklin Elmer and Merck KgaA among others

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Proteomics Market Across the Globe
    • 4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies
    • 4.2.3 Wide Applications of the Western Blot Test
  • 4.3 Market Restraints
    • 4.3.1 Availability of the Alternatives for Western Blot
    • 4.3.2 Accuracy Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Instruments
      • 5.1.1.1 Gel Electrophoresis Instruments
      • 5.1.1.2 Blotting Systems
      • 5.1.1.3 Imagers
      • 5.1.1.3.1 Chemiluminescent Imagers
      • 5.1.1.3.2 Fluorescent Imagers
      • 5.1.1.3.3 Others
    • 5.1.2 Consumables
      • 5.1.2.1 Reagents
      • 5.1.2.2 Kits
  • 5.2 By Application
    • 5.2.1 Biomedical & Biochemical Research
    • 5.2.2 Disease Diagnostics
    • 5.2.3 Others
  • 5.3 By End-User
    • 5.3.1 Academia and Research Institutes
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bio-Rad Laboratories, Inc.
    • 6.1.2 Thermo Fisher Scientific, Inc.
    • 6.1.3 LI-COR Biosciences
    • 6.1.4 Bio-Techne Corporation
    • 6.1.5 Merck KGaA
    • 6.1.6 PerkinElmer, Inc.
    • 6.1.7 Cell Signaling Technology
    • 6.1.8 Advansta, Inc.
    • 6.1.9 Danaher Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS